Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation
Squawk Pod - Un pódcast de CNBC
Categorías:
A new study from the NIAID revealed that at least 50% of Covid-19 patients treated with a 5-day dosage of Gilead’s Remdesivir reported improved symptoms and were discharged from the hospital within two weeks. Former FDA Commissioner Dr. Scott Gottlieb describes the treatment as “part of a better toolbox” for fighting the coronavirus, but “not a home run.” Plus, Mindy Grossman, CEO of WW International, (formerly known as Weight Watchers) discusses keeping her business and our bodies well during quarantine. Learn more about your ad choices. Visit megaphone.fm/adchoices
